A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Solid Tumor, Adult · Colorectal Cancer · NSCLC · Non Small Cell Lung Cancer · NSCLC, Recurrent · Non-Small Cell Squamous Lung Cancer · Pancreas Cancer · Pancreatic Neoplasm · Colorectal Adenocarcinoma · CRC · Colon Cancer · Rectal Cancer · Cancer · Ovarian Cancer · Ovarian Neoplasms · Mesothelioma · Mesothelioma, Malignant · Ovary Cancer · Lung Cancer · MESOM

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Banner Health, Gilbert, Arizona, United States
Contact: Study coordinator (Yasmin Adam) · Yasmin.Adam2@bannerhealth.com
Contact: Principal Investigator (Matthew Ulrickson, MD)
UCSD Moores Cancer Center, La Jolla, California, United States
Contact: Study coordinator (Jona Plevin) · jplevin@health.ucsd.edu
Contact: Principal Investigator (Sandip Patel, MD)
UCLA Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Nicole Williams) · NSowden@mednet.ucla.edu
Contact: Principal Investigator (J. Randolph Hecht, MD)
Stanford University, Stanford, California, United States
Contact: Study coordinator (Kayla McDaniel) · mcda59@stanford.edu
Contact: Principal Investigator (Oliver Dorigo, MD)
Mayo Clinic, Jacksonville, Florida, United States
Contact: Study coordinator (Rhoda Romain) · Romain.Rhoda@mayo.edu
Contact: Principal Investigator (Yanyan Lou, MD)
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Jarriaun Streets) · jarriaun.streets@moffitt.org
Contact: Principal Investigator (Monica Avila, MD)
Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Teri Heddlesten Rediske) · HeddlestenRediske.Teri@mayo.edu
Contact: Principal Investigator (Julian Molina, MD, PhD)
Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Amberly Scott)
Study coordinator · amberly@wustl.edu
Contact: Principal Investigator (Jeffery Ward, MD)
NYU Langone Medical Center, New York, New York, United States
Contact: Study coordinator (Peter Warren) · Peter.Warren@nyulangone.org
Contact: Principal Investigator (Salman Punekar, MD)
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Dudbeth Brown) · Dudbeth.Brown@osumc.edu · 614-685-7034
Contact: Principal Investigator (Jinesh Gheeya, MD, PhD)
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Vanderbilt-Ingram Cancer Center Clinical Trials Office (CTO) · CTIP@VUMC.ORG · 1-800-811-8480
Contact: Principal Investigator (Cathy Eng, M.D., FACP, FASCO)
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Shelby Colden)
Study coordinator · scolden2@fredhutch.org
Contact: Principal Investigator (David Zhen, MD)

מובילי המחקר

John Welch, MD, PhD
Study Director
A2 Biotherapeutics

צפייה במקור ב־ClinicalTrials.gov פנייה לחוקר (אימייל)